Efficacy of High and Low Intensity Percutaneous Electrolysis for the Treatment of Myofascial Pain Syndrome
NCT ID: NCT04390438
Last Updated: 2020-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2020-02-17
2020-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a randomized clinical trial with 3 parallel groups: 1) High intensity-short time percutaneous electrolysis; 2) Low intensity-long time percutaneous electrolysis; 3) dry needling control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness Of The Application Of Percutaneous Electrolysis On Muscular Scar Tissue.
NCT06713200
Neuromodulation vs. Electrolysis in Plantar Fasciitis
NCT05826301
Electrolysis in Patients With Low Back Pain
NCT06661070
Percutaneous Electrolysis and Vacuum Myofascial Therapy deviceTrial.
NCT04729400
Electrolysis in Patients With Chronic Plantar Fasciitis
NCT06674902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fifteen patients diagnosed with unilateral PFPS were divided in two experimental groups (high intensity percutaneous electrolysis and low intensity percutaneous electrolysis) and one active control group (dry needling. The duration of the study was 7 days with only one intervention. Pain pressure thresholds were assessed using an algometer before the intervention, immediately after the intervention and after 7 days and a Visual Analogue Scale was used before the treatment and after 7 days to rate the subjective anterior knee pain perception. Also a VAS was used to rate the pain perception during the intervention
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-Intensity short time percutaneous electrolysis
Application of a 0,66uA galvanic current in the active TrP through a needle during 10 seconds. During the 20 seconds left necessary to blind the patient and the examiner, the needle was inside but with no electrical current
Percutaneous Electrolysis
Needle emplacement with a galvanic electrical current
Low-Intensity long time percutaneous electrolysis
Application of a 0,22uA galvanic current in the active TrP through a needle during 30 seconds
Percutaneous Electrolysis
Needle emplacement with a galvanic electrical current
Dry needling
One acupuncture needle was placed in the active TrP to produce a local twitch response during 30 seconds
Dry needling
Needle emplacement without electrical current nor substance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Electrolysis
Needle emplacement with a galvanic electrical current
Dry needling
Needle emplacement without electrical current nor substance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of at least one active Trigger point
Exclusion Criteria
* Surgery or traumas
* Skin alterations or infections
* Prior 6 weeks DN nor PT treatment
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Francisco de Vitoria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan Antonio Valera-Calero, PT, Msc
Role: PRINCIPAL_INVESTIGATOR
Camilo Jose Cela University
Alberto Sanchez-Mayoral-Martín, PT
Role: STUDY_DIRECTOR
Free professional practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Camilo Jose Cela University
Villanueva de la Cañada, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
50997093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.